Long COVID Trial, Recruiting NCT07013903 Sponsor: Schön Klinik Berchtesgadener Land Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT07013903
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Post-COVID Syndrome (sometimes called Long COVID, recorded under the medical code U08.9)
  • People who score above 80 on the Barthel Index, which is a measure of how independently a person can carry out everyday activities like washing, dressing, and moving around (confirm with trial site)
  • People who have been referred to the specialist centre for Post-COVID rehabilitation involved in this trial
  • People who own a smartphone that can be used to receive digital questionnaires and run an app that measures heart rate variability
  • People who are willing and able to give written consent to take part

Who may not be able to join:

  • People who have a medical condition that makes Kneipp hydrotherapy (a type of water-based therapy) unsafe for them, such as serious heart conditions like severe heart failure, unstable chest pain, or a recent heart attack; serious vein conditions like an active blood clot in a leg vein; or serious neurological conditions like epilepsy that is not well controlled
  • People who already regularly practise Kneipp applications (the water-based treatments being studied in this trial)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rembert Koczulla, MD, Schön Klinik Berchtesgadener Land

Phone: +498652931630

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Schön Klinik Berchtesgadener Land
Registry
ClinicalTrials.gov
Start date
21 August 2025
Est. completion
31 January 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Health-related quality of life by Short Form-12 Health Survey (SF-12)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov